Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694473 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT00694473: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00694473 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00694473, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
We hypothesize that measurements of interstitial fluid (ISF) glucose by the FreeStyle Navigator (Abbot Diabetes Care), a continuous glucose monitoring system, will correlate with blood glucose (BG) values in surgical and ICU patients with a clinically useful degree of accuracy.
Interventions
- DEVICE Freestyle Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2008-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00694473
The ClinicalTrials.gov registry entry for NCT00694473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Freestyle Navigator is the first listed.
NCT00694473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00694473 about?
NCT00694473 is a clinical study titled "Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery". We hypothesize that measurements of interstitial fluid (ISF) glucose by the FreeStyle Navigator (Abbot Diabetes Care), a continuous glucose monitoring system, will correlate with blood glucose (BG) values in surgical and ICU patients with a clinically useful degree of accuracy.
What is the current status of trial NCT00694473?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2008-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT00694473?
The interventions under investigation include: Freestyle Navigator (DEVICE).
Who is sponsoring clinical trial NCT00694473?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.